Your browser doesn't support javascript.
loading
S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial.
Watanabe, J; Sasaki, S; Kusumoto, T; Sakamoto, Y; Yoshida, K; Tomita, N; Maeda, A; Teshima, J; Yokota, M; Tanaka, C; Yamauchi, J; Uetake, H; Itabashi, M; Takahashi, K; Baba, H; Kotake, K; Boku, N; Aiba, K; Morita, S; Takenaka, N; Sugihara, K.
Affiliation
  • Watanabe J; Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan. Electronic address: nabe-jun@comet.ocn.ne.jp.
  • Sasaki S; Department of Surgical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Kusumoto T; Department of Gastrointestinal Surgery and Clinical Research Institute Cancer Research Division, National Kyushu Medical Center, Fukuoka, Japan.
  • Sakamoto Y; Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan.
  • Yoshida K; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Tomita N; Division of Lower GI Surgery, Department of Surgery, Hyogo College of Medicine, Hyogo, Japan.
  • Maeda A; Department of Surgery, Ogaki Municipal Hospital, Gifu, Japan.
  • Teshima J; Department of Gastrointestinal Surgery, Iwate Prefectural Central Hospital, Iwate, Japan.
  • Yokota M; Department of General Surgery, Kurashiki Central Hospital, Okayama, Japan.
  • Tanaka C; Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan.
  • Yamauchi J; Department of Surgery, Sendai Kousei Hospital, Miyagi, Japan.
  • Uetake H; Department of Specialized Surgeries, Tokyo Medical and Dental University, Tokyo, Japan.
  • Itabashi M; Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
  • Takahashi K; Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Baba H; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Kotake K; Department of Surgery, Sano City Hospital, Tochigi, Japan.
  • Boku N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Aiba K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Tokyo Jikei University School of Medicine, Tokyo, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Takenaka N; Clinical Research & Pharmacoepidemiology Department, Medical Affairs Division, Taiho Pharmaceutical Co., Ltd, Tokyo, Japan.
  • Sugihara K; Tokyo Medical and Dental University, Tokyo, Japan.
ESMO Open ; 6(2): 100077, 2021 04.
Article de En | MEDLINE | ID: mdl-33714860
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Uracile / Leucovorine / Tégafur / Tumeurs du côlon / Oxaliplatine Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies Limites: Humans Langue: En Journal: ESMO Open Année: 2021 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Uracile / Leucovorine / Tégafur / Tumeurs du côlon / Oxaliplatine Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies Limites: Humans Langue: En Journal: ESMO Open Année: 2021 Type de document: Article